The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
This partnership stemmed from a successful customer-supplier relationship spanning several years.
The investment will enable the company to enter European markets as well as enhance margins in current markets
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Company to open new headquarters in 2024
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
The initiative has garnered the distinction of being the world’s largest government owned telemedicine platform
Soluplus branded excipient play a critical role in enabling the drug development process for poorly soluble active pharmaceutical ingredients
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
Subscribe To Our Newsletter & Stay Updated
